# Salvo Health

> Salvo Health gives gastroenterology practices the people and software to care for chronic GI, liver and obesity patients between office visits. Its app connects patients with dietitians, GI-trained nurses and behavioral-health support, while its Sano platform updates care plans, tracks symptoms and returns useful information to the referring practice. The company began as a $127-a-month virtual clinic for consumers, then found greater leverage by helping local doctors add insurance-covered remote monitoring and continuous care.

- **Founded:** 2021
- **Headquarters:** New York, United States
- **Founders:** Jeffrey Glueck (Co-Founder and CEO), Avi Dorfman (Co-Founder, Lead Board Director and Advisor), Jason Finger (Co-Founder, Board Member and Advisor)
- **Products:** Salvo Wraparound Care, Sano, Salvo mobile app, Remote patient monitoring enablement, GLP-1 and anti-obesity medication support
- **Notable:** Signed agreements with 801 GI physicians, which Salvo said represented 16% of independent U.S. gastroenterologists, by early 2026., Reported 800% year-over-year growth in patients and revenue during 2025 and more than 1,000% growth in enterprise agreements with GI doctors., Reported that 76% of participating patients improved after at least four weeks and 84% rated the experience better than prior healthcare.

## Products & services

- **Salvo Wraparound Care** — Insurance-covered follow-on care for chronic GI, metabolic liver and obesity patients, delivered with registered dietitians, GI-trained nurses, behavioral-health support, messaging and monthly virtual visits.
- **Sano** — A proprietary clinical technology stack that orchestrates personalized care plans, patient engagement and data sharing with provider practices.
- **Salvo mobile app** — Patient-facing tools for daily symptom and biometric tracking, messaging, virtual visits, education and evolving care plans.
- **Remote patient monitoring enablement** — Staffing, software, EHR documentation and operational support that allow practices to offer and bill for RPM and chronic-care services.
- **GLP-1 and anti-obesity medication support** — Nutrition, movement, behavioral and medication-adherence support across the start, titration and maintenance stages of treatment.

## Achievements

- Signed agreements with 801 GI physicians, which Salvo said represented 16% of independent U.S. gastroenterologists, by early 2026.
- Reported 800% year-over-year growth in patients and revenue during 2025 and more than 1,000% growth in enterprise agreements with GI doctors.
- Reported that 76% of participating patients improved after at least four weeks and 84% rated the experience better than prior healthcare.
- Reported a 79% reduction in GI-related emergency and urgent-care utilization in a two-arm study.
- Won a Blue Ribbon at the American College of Gastroenterology annual meeting for research that included symptom and mental-health outcomes.
- Raised $8.5 million in Series A financing announced in January 2026.

## Latest updates

- **2024-02** — Raised $5 million to expand provider enablement and named local physicians as the hub of its hybrid-care model.
- **2024-03** — Partnered with Lohman Technologies to add cellular-connected home monitoring for chronic GI care.
- **2024-05** — Partnered with Pinnacle GI Partners to bring wraparound care to patients in Michigan.
- **2025-06** — Passed 700 contracted GI physicians and raised a $4 million Seed Prime round for deployments in nine new states.
- **2026-01** — Announced an $8.5 million Series A, 801 signed GI physicians and plans to expand engineering, AI capabilities and clinical hiring.

## Links

- Website: https://www.salvohealth.com/
- LinkedIn: https://www.linkedin.com/company/salvohealth/
- Twitter/X: https://twitter.com/salvohealth
- Instagram: https://www.instagram.com/salvohealth/
- Facebook: https://www.facebook.com/SalvoHealth

---

Profile page: https://yespress.io/salvo-health
Published by YesPress — https://yespress.io
Last updated: 2026-09-26